PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Projects
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Pricing and Market Access
Events
Reports
Premium Insights
Excellence Awards
Magazine
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Accelerating Clinical Trials
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment
Projects
Latest
Sentiment towards Brexit has worsened three years after UK left EU
US companies drive 2023 drug launches positioned for blockbuster success by 2028
Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Latest
Fusion's Radiopharmaceutical Manufacturing Facility, Ontario, Canada
Janssen submits NDA to FDA for PAH combination therapy
Stealth and Pharmanovia partner for commercialisation of elamipretide
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
XtalPi announces $250m AI drug discovery collaboration with Eli Lilly
University of Sydney will use AI to boost cancer drug research
Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Who’s investing where? Private equity deal activity in the pharmaceutical industry in North America decreased by 30% in Q1 2023
Who’s acquiring who? M&A activity in the pharmaceutical industry in Asia-Pacific decreased by 31% in Q1 2023
Who’s acquiring who? M&A activity in the pharmaceutical industry in Europe decreased by 37% in Q1 2023
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Latest
Communications in life sciences: Uncovering the Unlocked survey results
Medicines adherence: Overcoming pharma’s biggest barrier to treatment success
Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Events
Reports
Premium Insights
PT
September 2, 2020
2nd Glioblastoma Drug Development Summit
By
IndiaProduction
IndiaProduction
Share this article
Recommended Reports
Reports
PharmaPoint: Fibromyalgia – Global Drug Forecast and Market Analysis to 2023
GlobalData
Reports
Neuromyelitis Optica (Devic’s Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecul...
GlobalData
View all
IndiaProduction
